Alzheimer's disease (AD) is a progressive neurodegenerative disease that is most prevalent
in females. While estrogen provides neuroprotection in females, sex mediated differences in …

Introduction Epidemiological studies show that women have a higher prevalence of
Alzheimer's disease (AD) than men. Peripheral estrogen reduction during aging in women is …

Alzheimer's disease (AD) is the most common cause of dementia. Despite many years of
research, very limited treatment options are available. Here we aim to establish a well …

Women carry a higher burden of Alzheimer's disease (AD) compared to men, which is not
accounted entirely by differences in lifespan. To identify the mechanisms underlying this …

Clinical studies have shown that female brains are more predisposed to neurodegenerative
diseases such as Alzheimer's disease (AD), but the cellular and molecular mechanisms …

It has been suggested that there is a critical window for estrogen replacement therapy (ERT)
in postmenopausal women with Alzheimer's disease (AD); however, supporting evidence is …

Background: The prevalence of Alzheimer's disease (AD) is greater in women compared to
men, but the reasons for this remain unknown. This sex difference has been widely …

Background: Alzheimer's disease (AD) is characterized by progressive neuronal loss and
cognitive decline. Epidemiological studies suggest that the risk of AD is higher in women …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
memory loss and impaired cognitive functions. The higher incidence of AD among women …

Female sex and Apolipoprotein E (APOE) ε4 genotype are top non-modifiable risk factors for
Alzheimer's disease (AD). Although female-unique experiences like parity (pregnancy and …